ASH Launches Permexa Sodium Caprate to Support Oral Biologics Growth
Ashland launches Permexa sodium caprate to support oral peptide and biologic development with enhanced processing and permeability.
ASH - Ashland Inc.
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$78.71
DETAILS
HIGH:
$85.00
LOW:
$75.00
MEDIAN:
$78.00
CONSENSUS:
$78.71
UPSIDE:
5.91%
Stock News
Deutsche Bank AG Buys Shares of 83,987 Ashland Inc. $ASH
Deutsche Bank AG purchased a new stake in Ashland Inc. (NYSE: ASH) in the undefined quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 83,987 shares of the basic materials company's stock, valued at approximately $5,534,000. Deutsche Bank AG owned 0.18% of Ashland
Ashland advances high-growth oral biologics delivery applications with launch of permexa™ sodium caprate
WILMINGTON, Del., Aug. 24, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), is announcing the launch of permexa™ sodium caprate, a high-performance intestinal permeation enhancer designed to support the scalable development and commercialization of oral peptide, biologic and low-permeability drug products, including rapidly expanding GLP-1 agonists and related therapeutic pipelines.
Bank of America Corp DE Sells 22,944 Shares of Ashland Inc. $ASH
Bank of America Corp DE cut its holdings in shares of Ashland Inc. (NYSE: ASH) by 4.9% during the undefined quarter, according to its most recent Form 13F filing with the SEC. The firm owned 445,596 shares of the basic materials company's stock after selling 22,944 shares during the period. Bank of America
Ashland Inc.: Activist Pressure Starts To Pay Off
Ashland Inc. (ASH) remains a Buy, with the investment case now centered on activist-driven M&A potential and strategic alternatives. Life Sciences and Personal Care segments, comprising 82% of gross EBITDA, continue to deliver growth and margin stability, underpinning valuation. Multiple activist investors, including Standard Industries and Ancora, have driven board changes, capital allocation reviews, and engagement with potential acquirers.
Ashland Now a ‘Gig-Ready' Community From Kinetic's Fiber-Optic Network Expansion
More than 75% of homes in community now have access to Kinetic's Multi-Gig, Next-Generation internet 14,000 locations benefit from better internet experience supporting economic growth, telehealth, work, streaming ASHLAND, Ky., Aug. 12, 2026 (GLOBE NEWSWIRE) -- Kinetic, the leading insurgent residential and business fiber internet provider, announced today that Ashland is officially recognized as a Kinetic ‘Gig-Ready Community,' meaning more than 75% of the area's homes now have access to Kinetic's high-speed, next generation internet.
Leon Cooperman Buys Ashland Inc (ASH) -- Shares Look 9% Overvalued on GF Value
On July 29, 2026, Leon Cooperman (Trades, Portfolio)'s firm executed a significant "Add" transaction for Ashland Inc (ASH, Financial), increasing the position b
Kardigan Reports Second Quarter 2026 Financial Results and Recent Business Updates
Kardiganâ¢, Inc. (Nasdaq: KARD) (âKardiganâ or âthe Companyâ), a clinical-stage precision therapeutics company developing medicines that target the roo
Ashland board authorizes quarterly dividend
WILMINGTON, Del., Aug. 07, 2026 (GLOBE NEWSWIRE) -- The board of directors of Ashland Inc. (NYSE: ASH) has declared a quarterly cash dividend of $0.42 cents per share on the company's common stock.
Glenmede Trust Co. NA Has $10.64 Million Stake in Ashland Inc. $ASH
Glenmede Trust Co. NA lowered its stake in Ashland Inc. (NYSE: ASH) by 8.4% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 191,305 shares of the basic materials company's stock after selling 17,450 shares during the quarter. Glenmede Trust Co.
Ashland Inc. (ASH) Q3 2026 Earnings Call Transcript
Ashland Inc. (ASH) Q3 2026 Earnings Call Transcript
Ashland Q3 Earnings Call Highlights
Ashland NYSE: ASH reported higher sales across all four business units in its fiscal third quarter of 2026, supported by volume growth, pricing actions and demand in its Life Sciences and Personal Care operations. The company reaffirmed its full-year sales and adjusted EBITDA outlook, while lowering its adjusted earnings-per-share growth forecast because of a higher tax rate tied to unfavorable discrete items.
Ashland Analysts Increase Their Forecasts After Strong Q2 Results
Ashland Inc (NYSE:ASH) on Tuesday posted better-than-expected earnings for the second quarter.
Ashland's Q3 Earnings Miss Estimates, Sales Beat on Volume Growth
ASH's Q3 sales beat estimates as volume growth lifted all segments, but adjusted earnings missed and the company lowered its fiscal 2026 EPS growth outlook.
Ashland (ASH) Q3 Earnings Lag Estimates
Ashland (ASH) came out with quarterly earnings of $1.02 per share, missing the Zacks Consensus Estimate of $1.03 per share. This compares to earnings of $1.04 per share a year ago.
Ashland (ASH) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Ashland (ASH) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ashland reports third quarter 2026 results and reaffirms full-year sales & Adjusted EBITDA outlook
Sales of $497 million, up seven percent from the prior-year quarter Income from continuing operations of $41 million, or $0.89 per diluted share Adjusted Income from Continuing Operations Excluding Intangibles Amortization Expense of $47 million, or $1.02 per diluted share Net income of $16 million, or $0.35 per diluted share Sales volumes rose six percent from the prior-year quarter, with gains achieved across all business units Adjusted EBITDA of $109 million, down four percent from the prior-year quarter, primarily reflecting growth in Life Sciences and Personal Care, more than offset by lower Specialty Additives and Intermediates earnings Cash flows provided by operating activities of $121 million; Ongoing Free Cash Flow2 of $103 million Reaffirming full‑year fiscal 2026 sales guidance of $1,835-$1,870 million and Adjusted EBITDA guidance of $385-$400 million WILMINGTON, Del., July 28, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced financial results1 for the third quarter of fiscal year 2026, which ended June 30, 2026, and reaffirmed its full-year fiscal 2026 sales and Adjusted EBITDA outlook.
Ashland announces appointment of two new directors as part of Cooperation Agreement with stockholder Ancora
WILMINGTON, Del., July 28, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH), a global leader in additives and specialty ingredients, today announced the appointments of two new independent members of the Company Board of Directors and the formation of a Capital Allocation Advisory Committee as part of entry into a cooperation agreement with Ancora Holdings Group, LLC, a meaningful stockholder.
Ashland (ASH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Ashland (ASH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Ashland sets date for third-quarter fiscal 2026 earnings release and conference call webcast
WILMINGTON, Del. , July 14, 2026 (GLOBE NEWSWIRE) -- Ashland Inc. (NYSE: ASH) today announced plans to issue its third-quarter fiscal 2026 earnings release at approximately 5 p. m. ET on Tuesday, July 28, 2026.
Price Targets
Ashland price target raised to $78 from $58 at Morgan Stanley
$78.00
(was $71.69)
Morgan Stanley
Ashland price target raised to $85 from $74 at Deutsche Bank
$85.00
(was $72.00)
Deutsche Bank
Ashland price target raised to $83 from $75 at UBS
$83.00
(was $72.08)
UBS
Ashland price target raised to $75 from $68 at BMO Capital
$75.00
(was $68.01)
John McNulty
·
BMO Capital
Ashland price target raised to $77 from $75 at Mizuho
$77.00
(was $68.01)
Mizuho Securities
Ashland Inc. (ASH) PT Raised to $78 at Wolfe Research
$78.00
(was $66.38)
Chris Parkinson
·
Wolfe Research
Ashland price target raised to $72 from $66 at UBS
$72.00
(was $62.50)
UBS
Ashland upgraded to Buy from Neutral at Seaport Research
$75.00
(was $52.26)
Michael Harrison
·
Seaport Global
Ashland price target lowered to $58 from $63 at Morgan Stanley
$58.00
(was $52.93)
Steven Haynes
·
Morgan Stanley
Ashland price target lowered to $60 from $70 at Deutsche Bank
$60.00
(was $53.26)
David Begleiter
·
Deutsche Bank
Ashland price target raised to $62 from $53 at Evercore ISI
$62.00
(was $61.48)
Evercore ISI
Ashland price target raised to $63 from $60 at Morgan Stanley
$63.00
(was $64.16)
Morgan Stanley
Ashland price target raised to $73 from $70 at UBS
$73.00
(was $65.31)
UBS
Ashland price target raised to $70 from $58 at Deutsche Bank
$70.00
(was $61.08)
David Begleiter
·
Deutsche Bank
Ashland price target raised to $70 from $64 at UBS
$70.00
(was $63.78)
UBS
Ashland price target raised to $70 from $65 at Argus
$70.00
(was $62.90)
Argus Research
Ashland price target raised to $70 from $60 at Mizuho
$70.00
(was $59.77)
John Roberts
·
Mizuho Securities
Ashland upgraded to Outperform from Market Perform at BMO Capital
$71.00
(was $59.15)
BMO Capital
Ashland price target lowered to $52 from $53 at Wells Fargo
$52.00
(was $49.01)
Michael Sison
·
Wells Fargo
Ashland price target lowered to $54 from $58 at Mizuho
$54.00
(was $48.54)
John Roberts
·
Mizuho Securities